Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder Harmony Biosciences' FDA setback for pitolisant in idiopathic hypersomnia doesn't impact its 2025 revenue outlook ...
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback